Skip to main content
[Preprint]. 2024 Jun 3:rs.3.rs-4244833. [Version 1] doi: 10.21203/rs.3.rs-4244833/v1

Extended Table 3a.

Summary of serum concentrations of 2141-V11 in cycle 1 (ng/mL)

Cycle/Day Timepoint Statistics Dose 1
0.7 mg (n=3)
Dose 2
2.0 mg (n=3)
Dose 3
7.0 mg (n=3)
Dose 4
10.0 mg (n=3)
Cycle 1 - Day 1 Predose n 3 3 3 3
Mean 0.000 0.000 0.000 0.000
SD 0.000 0.000 0.000 0.000
Median 0.000 0.000 0.000 0.000
Min 0.000 0.000 0.000 0.000
Max 0.000 0.000 0.000 0.000
CV% NC NC NC NC

15 minutes n 3 3 3 3
Mean 0.000 0.000 45.400 564.600
SD 0.000 0.000 78.640 611.800
Median 0.000 0.000 0.000 362.200
Min 0.000 0.000 0.000 79.660
Max 0.000 0.000 136.200 1252.000
CV% NC NC 173.2 108.4

2 hour n 3 3 3 3
Mean 0.000 0.000 48.900 286.400
SD 0.000 0.000 84.700 323.400
Median 0.000 0.000 0.000 142.200
Min 0.000 0.000 0.000 60.070
Max 0.000 0.000 146.700 656.800
CV% NC NC 173.2 112.9

6 hour n 3 3 3 3
Mean 0.000 0.000 41.53 93.53
SD 0.000 0.000 71.94 162
Median 0.000 0.000 0.000 0.000
Min 0.000 0.000 0.000 0.000
Max 0.000 0.000 124.6 280.6
CV% NC NC 173.2 173.2

24 hour n 3 3 3 3
Mean 0.000 0.000 0.000 0.000

Cycle 1 - Day 4 96 hour n 2 3 3 3
Mean 0.000 0.000 0.000 0.000

Cycle 1 - Day 8 192 Hour n 2 3 3 3
Mean 0.000 0.000 0.000 0.000

Cycle 1 - Day 15 360 Hour n 2 3 3 3
Mean 0.000 0.000 0.000 0.000

CV% = Coefficient of variation; Min = Minimum; Max = Maximum; SD = Standard Deviation; NC = Not Calculable. n = number of PK evaluable patients